<- Go Home
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc. offers ophthalmic products for cataract and laser refractive surgery. It offers surgical systems that include precision laser system; phacoemulsification systems and accessories including foot pedals, handpieces, and phacoemulsification packs; compact intuitive system; advanced femtosecond laser; excimer laser; advanced wave scan studio system; and StabilEyes capsular tension ring. It also provides ophthalmic viscoelastic devices and intraocular lens that includes multi-focal, toric, and mono-focal lens, and implants. Johnson & Johnson Surgical Vision, Inc. was formerly known as Abbott Medical Optics Inc. and changed its name to Johnson & Johnson Surgical Vision, Inc. in February 2017. The company was founded in 1976 and is based in Jacksonville, Florida. Johnson & Johnson Surgical Vision, Inc. operates as a subsidiary of Johnson & Johnson.
Market Cap
$1.4B
Volume
1.0M
Cash and Equivalents
$50.7M
EBITDA
$269.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$722.2M
Profit Margin
60.94%
52 Week High
$24.90
52 Week Low
$2.88
Dividend
N/A
Price / Book Value
2.12
Price / Earnings
22.66
Price / Tangible Book Value
-1.21
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$154.8M
Return on Equity
9.86%
Return on Assets
3.66
Cash and Short Term Investments
$50.7M
Debt
$1.4B
Equity
$639.6M
Revenue
$1.2B
Unlevered FCF
$172.2M
Sector
Health Care Equipment and Supplies
Category
N/A